Tobias Roider

18PUBLICATIONS
101CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursTumour immunologyGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 07, 2025
Integrative multi-omics reveals a regulatory and exhausted T-cell landscape in CLL and identifies galectin-9 as an immunotherapy target.

L Llaó-Cid, Jkl Wong, I Fernandez Botana

|Jan 30, 2025
Blocking the CD39/CD73 pathway synergizes with anti-CD20 bispecific antibody in nodal B-cell lymphoma.

Clara Kolbe, Joseph Kauer, Berit Brinkmann

|Apr 29, 2024
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia.

Philipp M Roessner, Isabelle Seufert, Vicente Chapaprieta

|Apr 13, 2024
Asciminib Maintains Antibody-Dependent Cellular Cytotoxicity against Leukemic Blasts.

Samuel J Holzmayer, Joseph Kauer, Jonas Mauermann

|Feb 21, 2024
Multimodal and spatially resolved profiling identifies distinct patterns of T cell infiltration in nodal B cell lymphoma entities.

Tobias Roider, Marc A Baertsch, Donnacha Fitzgerald

|Oct 02, 2023
Ex vivo drug response profiling for response and outcome prediction in hematologic malignancies: the prospective non-interventional SMARTrial.

Nora Liebers, Peter-Martin Bruch, Tobias Terzer

Pageof 3

Frequent Collaborators

9 joint publications

Sascha Dietrich

9 joint publications

Peter-Martin Bruch

7 joint publications

Wolfgang Huber

6 joint publications

Sophie A Herbst